Follistatin Antikörper

Produktnummer ABIN636639

Dieses Anti-Follistatin-Antikörper ist ein Kaninchen Polyklonal-Antikörper zur Detektion von Follistatin in WB, ELISA und Inhibition. Geeignet für Human.

Kurzübersicht für Follistatin Antikörper (ABIN636639)

Target: Follistatin (FST)

Reaktivität: Human

Wirt: Kaninchen

Klonalität: Polyklonal

Konjugat: Dieser Follistatin Antikörper ist unkonjugiert

Applikation: Western Blotting (WB), ELISA, Blocking Antibody (Inhibition)

Produktdetails anti-Follistatin Antikörper

Aufreinigung: Purified

Immunogen: Follistatin antibody was raised in rabbit using highly pure recombinant human Follistatin as the immunogen.

Anwendungsinformationen

Applikationshinweise: ELISA: 0.5-2 µg/mL, Inhibition: 8-12 µg/mL, WB: 0.1-0.2 µg/mL
Optimal conditions should be determined by the investigator.

Beschränkungen: Nur für Forschungszwecke einsetzbar

Handhabung

Format: Lyophilized

Konzentration: Lot specific

Buffer: Lyophilized from PBS, pH 7.2.

Handhabung: Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use.

Lagerung: 4 °C/-20 °C

Informationen zur Lagerung: Store at -20 °C until reconstitution. Following reconstitution product may be stored at 4 °C in the short term. For long term storage aliquot and freeze at -20 °C.

Details zu Follistatin

Target: Follistatin (FST)

Andere Bezeichnung: Follistatin

Hintergrund: Follistatin is a secreted protein that binds to ligands of the TGF beta family and regulates their activity by inhibiting their access to signaling receptors. It was originally discovered as activin antagonists whose activity suppresses expression and secretion of the pituitary hormone FSH (follicle stimulating hormone). In addition to being a natural antagonist, follistatin can inhibit the activity of other TGF beta ligands including BMP-2, -4, -6, -7, Myostatin, GDF-11, and TGF beta1. Follistatin is expressed in the pituitary, ovaries, decidual cells of the endometrium, and in some other tissues.

Molekulargewicht: 31.5 kDa (predicted detection band MW)

Pathways: Negative Regulation of Hormone Secretion